Frequency of Electrolyte Abnormalities in Cirrohsis Patient Presenting with Hepatic Encephalopathy
DOI:
https://doi.org/10.70749/ijbr.v4i5.3239Keywords:
Cirrhosis, hyponatremia, hypokalemia, hepatic encephalopathy, electrolyte abnormality, Child-Pugh classAbstract
Background: Liver cirrhosis is a chronic progressive liver disease which can develop into several complications such as hepatic encephalopathy. Hepatic encephalopathy (HE) is a serious neuropsychiatric complication of liver dysfunction that is often triggered by infection, gastrointestinal bleeding, constipation, renal insufficiency and electrolyte imbalance. Severe disease and further deterioration of cerebral function may occur in patients with cirrhosis due to electrolyte disturbances, particularly hyponatremia and hypokalemia. Objective: To determine the frequency of electrolyte abnormalities among cirrhosis patients presenting with hepatic encephalopathy. Methods: This descriptive cross-sectional study was conducted at Lahore General Hospital, Lahore, Pakistan from January 2025 to June 2025. There were 75 patients who had a diagnosis of liver cirrhosis and hepatic encephalopathy. A structured proforma was used to record demographic data, clinical history, aetiology of cirrhosis, grade of hepatic encephalopathy, precipitating factors and hospital outcomes. Blood samples were taken on admission for renal function tests, liver function tests, INR, serum sodium, serum potassium, serum chloride, serum calcium, and serum magnesium. An electrolyte abnormality was present if any electrolyte level in the serum was outside the laboratory normal reference range. The analysis of data was carried out by SPSS version 25. Qualitative variables were presented in terms of frequencies and percentages, and quantitative variables were presented as mean and standard deviation. With a p value less than 0.05 it was deemed to be statistically significant. Results: The mean age of patients was 52.6 ± 11.4 years. Out of 75 patients, 48 (64.0%) were males and 27 (36.0%) were females. Most patients had advanced liver disease, with 40 (53.3%) patients classified as Child-Pugh class C. Grade II hepatic encephalopathy was the most common presentation, observed in 30 (40.0%) patients. Overall, 56 (74.7%) patients had at least one electrolyte abnormality. Hyponatremia was the most frequent abnormality, present in 42 (56.0%) patients, followed by hypokalemia in 27 (36.0%), hypocalcemia in 20 (26.7%), and hypomagnesemia in 15 (20.0%) patients. Electrolyte abnormalities were significantly associated with higher grades of hepatic encephalopathy (p = 0.031) and increased in-hospital mortality (p = 0.046). Conclusion: Electrolyte abnormalities were highly frequent among cirrhosis patients presenting with hepatic encephalopathy. Hyponatremia was the most common abnormality, followed by hypokalemia. The presence of electrolyte imbalance was associated with more severe hepatic encephalopathy and poor hospital outcome. Routine assessment and timely correction of serum electrolytes should be part of the initial management of cirrhotic patients presenting with hepatic encephalopathy.
Downloads
References
1. Kowshik MM, Islam N, Ahmed F, Parveen M, Das PPJJoC, Research AM. Association between Serum Electrolyte Level and Outcomes among Hospitalized Liver Cirrhosis Patients Presented with Hepatic Encephalopathy Admitted at a Tertiary Care Hospital. 2023;10(1):41-6.
https://doi.org/10.3329/jcamr.v10i1.69970
2. Duah A, Agyei-Nkansah A, Osei-Poku F, Duah F, Ampofo-Boobi D, Peprah BJCjog, et al. The prevalence, predictors, and in‐hospital mortality of hepatic encephalopathy in patients with liver cirrhosis admitted at St. Dominic Hospital in Akwatia, Ghana. 2020;2020(1):8816522.
https://doi.org/10.1155/2020/8816522
3. Sahney A, Wadhawan MJJoC, Hepatology E. Encephalopathy in cirrhosis: prevention and management. 2022;12(3):927-36.
https://doi.org/10.1016/j.jceh.2021.12.007
4. Shaw J, Beyers L, Bajaj JSJJoHM. Inadequate practices for hepatic encephalopathy management in the inpatient setting. 2022;17:S8-S16.
https://doi.org/10.1002/jhm.12897
5. Ullah H, Shabana H, Rady MA, Abdelsameea E, Youssef MI, Helmy HA, et al. Hypokalemia as a responsible factor related with the severity of hepatic encephalopathy: a wide multination cross-sectional study. 2023;85(6):2427-31.
https://doi.org/10.1097/ms9.0000000000000470
6. Warner ER, Aloor FZ, Satapathy SKJTg, hepatology. A narrative review of nutritional abnormalities, complications, and optimization in the cirrhotic patient. 2022;7:5.
https://doi.org/10.21037/tgh-20-325
7. Hafez MZE, Abdallah HAM, Hamad MAMJTEJoHM. Assessment of precipitating factors and outcomes of hepatic encephalopathy in cirrhotic patients. 2020;81(3):1718-21.
https://doi.org/10.21608/ejhm.2020.118575
8. Bajaj JS, Gentili A, Wade JB, Godschalk MJCG, Hepatology. Specific challenges in geriatric cirrhosis and hepatic encephalopathy. 2022;20(8):S20-S9.
https://doi.org/10.1016/j.cgh.2022.04.035
9. Sîngeap AM, Cuciureanu T, Zenovia S, Girleanu I, Huiban L, Muzica CM, et al. Spectrum of Precipitating Factors of Hepatic Encephalopathy in Patients with Liver Cirrhosi. 2021;125(4):492-501.
https://doi.org/10.1016/j.cgh.2022.04.035
10. Duriseti P, Mamtani R, Madias NE, Strom JAJTAJotMS. Alkalemia and Hepatic Encephalopathy in a Chronic Dialysis Patient. 2021;362(2):207-10.
https://doi.org/10.1016/j.amjms.2020.12.016
11. Rudler M, Weiss N, Bouzbib C, Thabut DJCiLD. Diagnosis and management of hepatic encephalopathy. 2021;25(2):393-417.
https://doi.org/10.1016/j.cld.2021.01.008
12. Khan S, Butt NI, Tareen MQK, Sami H, Ashfaq F, Mahmood KJTPMJ. Hyponatremia in liver cirrhosis patients presenting with hepatic encephalopathy. 2022;29(07):970-4.
https://doi.org/10.29309/tpmj/2022.29.07.7057
13. Ullah T, Qasim MI, Shah SFA, Ullah I, editors. Precipitating factors of hepatic encephalopathy in patients with liver cirrhosis. Medical Forum Monthly; 2020.
14. Haj M, Rockey DCJOjotACoG, ACG. Ammonia levels do not guide clinical management of patients with hepatic encephalopathy caused by cirrhosis. 2020;115(5):723-8.
https://doi.org/10.14309/ajg.0000000000000343
15. Abdelaal UM, El-rahman A, allah Fadel H, Elbadry MIJSMJ. Impact of Serum levels of Bicarbonate and Electrolytes on Adverse Clinical Outcomes in Cirrhotics. 2023;27(3):34-46.
https://doi.org/10.21608/smj.2023.226275.1400
16. Bellafante D, Gioia S, Faccioli J, Riggio O, Ridola L, Nardelli SJJoCM. Old and new precipitants in hepatic encephalopathy: a new look at a field in continuous evolution. 2023;12(3):1187.
https://doi.org/10.3390/jcm12031187
17. Garcia-Martinez R, Diaz-Ruiz R, Poncela MJCDI. Management of hepatic encephalopathy associated with advanced liver disease. 2022;42(Suppl 1):5-13.
https://doi.org/10.1007/s40261-022-01146-6
18. Duah A, Nkansah A, Okine R, Duah FJPMJoG. Prevalence and precipitating factors of hepatic encephalopathy in patients with liver cirrhosis and ascites admitted at korle bu teaching hospital In Ghana. 2021;10(1):31-6.
https://doi.org/10.60014/pmjg.v10i1.248
19. Babak O, Zheleznyakova N, Shalimova A, Vizir M, Lapshyna K, Panchenko G, et al. Management of patients with acute hepatic encephalopathy. Modern practice of internal medicine with emergency conditions: guidelines for students and interns. 2021.
20. SafariKish B, Rafiei F, Ebrahimi A, AZIZI SF, Rafiei R. The relationship between plasma magnesium concentration and hepatic encephalopathy in liver cirrhosis patients: A preliminary result of a referral center in Iran. 2022.
https://doi.org/10.5812/mejrh-122978
21. Tapper EB, Parikh NDJJ. Diagnosis and management of cirrhosis and its complications: a review. 2023;329(18):1589-602.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Indus Journal of Bioscience Research

This work is licensed under a Creative Commons Attribution 4.0 International License.